血友病の世界市場2020-2027:市場規模、シェア、動向分析

Grand View Researchが発行した調査報告書(GV20MY051)
◆英語タイトル:Hemophilia Market Size, Share & Trends Analysis Report By Type (Type A, Type B, Type C), By Treatment (On-demand, Prophylaxis), By Therapy (Replacement Therapy, Gene Therapy), By Region, And Segment Forecasts, 2020 - 2027
◆商品コード:GV20MY051
◆発行会社(リサーチ会社):Grand View Research
◆発行日:2020年4月30日
◆ページ数:150
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥642,600見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥750,600見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥966,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGrand View Research社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。Grand View Research社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートでは、血友病の世界市場について調査・分析し、調査手法・範囲、エグゼクティブサマリー、市場要因・動向・範囲、種類別(タイプA、タイプB、タイプC)分析、治療別(オンデマンド、予防)分析、治療法別(補充療法、遺伝子治療、ITI療法)分析、地域別分析、競争分析などの構成でお届けいたします。
・調査手法・範囲
・エグゼクティブサマリー
・市場要因・動向・範囲
・血友病の世界市場:種類別(タイプA、タイプB、タイプC)
・血友病の世界市場:治療別(オンデマンド、予防)
・血友病の世界市場:治療法別(補充療法、遺伝子治療、ITI療法)
・血友病の世界市場:地域別
・競争分析
【レポートの概要】

The global hemophilia market size is expected to reach USD 18.1 billion by 2027, according to a new report by Grand View Research, Inc. It is anticipated to register a CAGR of 5.5% over the forecast period. Increasing awareness of early diagnosis and treatment coupled with supportive government policies is anticipated to boost market share over the forecast period.

For instance, the NHF (National Hemophilia Foundation) allows to find treatments for inheritable bleeding disorders and help prevent complications of these disorders through research, education, and advocacy. Their programs and initiatives are in association with the Centers for Disease Control and Prevention.

In addition, U.S. Hemophilia Treatment Center Network provides specialized healthcare centers and these offer care to address all psychological, educational, and physical needs of patients suffering from the disease. These centers currently provide care to more than 35,000 adults and children with the disease and other bleeding disorders.

The key market companies are projected to adopt strategic initiatives including geographic expansion and R&D especially in developing and underdeveloped regions, such as Middle Eastern and West African countries.

For instance, BioMarin is involved in developing Valoctocogene Roxaparvovec (BMN-270) for treating type A patients and is currently under clinical trials. Furthermore, in June 2017, the U.S. FDA accepted the investigational new drug application for Sanofi’s BIVV001 based on its preclinical study results.

Rising incidence of the disease is estimated to propel hemophilia market growth over the forecast period. According to the data published by the NHF, around 20,000 individuals in U.S. are suffering from this disease. In addition, approximately 75% of people with hemophilia receive inadequate treatment or have less/ no access to treatment globally.

Further key findings from the report suggest:

• Hemophilia A held the largest market share in 2019 due to its increasing prevalence worldwide

• Type B is expected to be the fastest growing type over the forecast period, at a CAGR of 6.8%

• On-demand dominated the treatment segment over the forecast period and is expected to contribute majority of the share in 2019

• Prophylaxis is estimated to be the fastest growing segment over the forecast period

• Replacement therapy was expected to be the largest segment in 2019

• Gene therapy dominated the therapy segment over the forecast period owing to increasing involvement of companies to develop more gene therapy for its treatment

• Increasing research and development and strategic collaborations are key strategies undertaken by major players in the market space.

【レポートの目次】

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market segmentation & scope
1.2. Information procurement
1.2.1. Purchased database
1.2.2. GVR’s internal database
1.2.3. Secondary sources & third party perspectives
1.2.4. Primary research
1.3. Information analysis
1.3.1. Data analysis models
1.4. Market formulation & data visualization
1.5. Data validation & publishing
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Hemophilia Market Variables, Trends & Scope
3.1. Market Lineage outlook
3.1.1. Parent/ Ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Product Pipeline Analysis
3.4. Regulation Framework
3.5. Market Dynamics
3.5.1. Market Driver Analysis
3.5.1.1. Increasing population of newborns
3.5.1.2. Favorable government initiative
3.5.1.3. Rising R&D and new product development
3.5.1.4. Rising adoption for prophylaxis treatment
3.5.2. Market Restraint Analysis
3.5.2.1. High cost associated to procure treatment
3.6. Hemophilia: Market Analysis Tools
3.6.1. Industry Analysis – Porter’s
3.6.1.1. Supplier Power: Moderate due to presence of suppliers in the market
3.6.1.2. Buyer Power: Low due to high cost of the treatment
3.6.1.3. Substitution Threat: High due to presence of internal substitutes
3.6.1.4. Threat from new entrant: Moderate due to presence of strong global presence of existing players
3.6.1.5. Competitive rivalry: High due to involvement of companies into developing novel therapies
3.6.2. PESTEL Analysis
3.6.2.1. Political Landscape
3.6.2.2. Environmental Landscape
3.6.2.3. Social Landscape
3.6.2.4. Technology Landscape
3.6.2.5. Legal Landscape
3.6.3. Major Deals & Strategic Alliances Analysis
3.6.3.1. Joint Ventures
3.6.3.2. Mergers & Acquisitions
3.6.3.3. Licensing & Partnership
3.6.3.4. Technology Collaborations
3.6.3.5. Strategic Divestments
Chapter 4. Hemophilia Market: Segment Analysis, By Type, 2016 – 2027 (USD Million)
4.1. Definitions & Scope
4.2. Type market share analysis, 2019 & 2027
4.3. Segment Dashboard
4.4. Global Hemophilia Market, By Type, 2016 to 2027
4.5. Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the following
4.5.1. Hemophilia A
4.5.2. Hemophilia B
4.5.3. Hemophilia C
4.5.4. Others
Chapter 5. Hemophilia market: Segment Analysis, By Treatment, 2016 – 2027 (USD Million)
5.1. Definitions & Scope
5.2. Treatment market share analysis, 2019 & 2027
5.3. Segment Dashboard
5.4. Global Hemophilia Market, By Treatment, 2016 to 2027
5.5. Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the following
5.5.1. On- demand
5.5.2. Prophylaxis
Chapter 6. Hemophilia market: Segment Analysis, By Therapy, 2016 – 2027 (USD Million)
6.1. Definitions & Scope
6.2. Therapy market share analysis, 2019 & 2027
6.3. Segment Dashboard
6.4. Global Hemophilia Market, By Therapy, 2016 to 2027
6.5. Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the following
6.5.1. Replacement therapy
6.5.2. Gene therapy
6.5.3. ITI therapy
Chapter 7. Hemophilia market: Regional Market Analysis, By Region, 2016 – 2027 (USD Million)
7.1. Definitions & Scope
7.2. Regional market share analysis, 2019 & 2027
7.3. Regional Market Dashboard
7.4. Regional Market Share and Leading Players, 2019
7.5. SWOT Analysis, by Factor (Political & Legal, Economic And Technological)
7.5.1. North America
7.5.2. Europe
7.5.3. Asia Pacific
7.5.4. Latin America
7.5.5. Middle East & Africa
7.6. Market Size, & Forecasts and Trend Analysis
7.7. North America
7.7.1. Market estimates and forecast, by country, 2016 – 2027 (USD Million)
7.7.2. Market estimates and forecast, by type, 2016 – 2027 (USD Million)
7.7.3. Market estimates and forecast, by treatment, 2016 – 2027 (USD Million)
7.7.4. Market estimates and forecast, by therapy, 2016 – 2027 (USD Million)
7.7.5. U.S.
7.7.5.1. Market estimates and forecast, by type, 2016 – 2027 (USD Million)
7.7.5.2. Market estimates and forecast, by treatment, 2016 – 2027 (USD Million)
7.7.5.3. Market estimates and forecast, by therapy, 2016 – 2027 (USD Million)
7.7.6. Canada
7.7.6.1. Market estimates and forecast, by type, 2016 – 2027 (USD Million)
7.7.6.2. Market estimates and forecast, by treatment, 2016 – 2027 (USD Million)
7.7.6.3. Market estimates and forecast, by therapy, 2016 – 2027 (USD Million)
7.8. Europe
7.8.1. Market estimates and forecast, by country, 2016 – 2027 (USD Million)
7.8.2. Market estimates and forecast, by type, 2016 – 2027 (USD Million)
7.8.3. Market estimates and forecast, by treatment, 2016 – 2027 (USD Million)
7.8.4. Market estimates and forecast, by therapy, 2016 – 2027 (USD Million)
7.8.5. Germany
7.8.5.1. Market estimates and forecast, by type, 2016 – 2027 (USD Million)
7.8.5.2. Market estimates and forecast, by treatment, 2016 – 2027 (USD Million)
7.8.5.3. Market estimates and forecast, by therapy, 2016 – 2027 (USD Million)
7.8.6. U.K.
7.8.6.1. Market estimates and forecast, by type, 2016 – 2027 (USD Million)
7.8.6.2. Market estimates and forecast, by treatment, 2016 – 2027 (USD Million)
7.8.6.3. Market estimates and forecast, by therapy, 2016 – 2027 (USD Million)
7.8.7. France
7.8.7.1. Market estimates and forecast, by type, 2016 – 2027 (USD Million)
7.8.7.2. Market estimates and forecast, by treatment, 2016 – 2027 (USD Million)
7.8.7.3. Market estimates and forecast, by therapy, 2016 – 2027 (USD Million)
7.8.8. Italy
7.8.8.1. Market estimates and forecast, by type, 2016 – 2027 (USD Million)
7.8.8.2. Market estimates and forecast, by treatment, 2016 – 2027 (USD Million)
7.8.8.3. Market estimates and forecast, by therapy, 2016 – 2027 (USD Million)
7.8.9. Spain
7.8.9.1. Market estimates and forecast, by type, 2016 – 2027 (USD Million)
7.8.9.2. Market estimates and forecast, by treatment, 2016 – 2027 (USD Million)
7.8.9.3. Market estimates and forecast, by therapy, 2016 – 2027 (USD Million)
7.9. Asia Pacific
7.9.1. Market estimates and forecast, by country, 2016 – 2027 (USD Million)
7.9.2. Market estimates and forecast, by type, 2016 – 2027 (USD Million)
7.9.3. Market estimates and forecast, by treatment, 2016 – 2027 (USD Million)
7.9.4. Market estimates and forecast, by therapy, 2016 – 2027 (USD Million)
7.9.5. China
7.9.5.1. Market estimates and forecast, by type, 2016 – 2027 (USD Million)
7.9.5.2. Market estimates and forecast, by treatment, 2016 – 2027 (USD Million)
7.9.5.3. Market estimates and forecast, by therapy, 2016 – 2027 (USD Million)
7.9.6. Japan
7.9.6.1. Market estimates and forecast, by type, 2016 – 2027 (USD Million)
7.9.6.2. Market estimates and forecast, by treatment, 2016 – 2027 (USD Million)
7.9.6.3. Market estimates and forecast, by therapy, 2016 – 2027 (USD Million)
7.9.7. India
7.9.7.1. Market estimates and forecast, by type, 2016 – 2027 (USD Million)
7.9.7.2. Market estimates and forecast, by treatment, 2016 – 2027 (USD Million)
7.9.7.3. Market estimates and forecast, by therapy, 2016 – 2027 (USD Million)
7.9.8. Australia
7.9.8.1. Market estimates and forecast, by type, 2016 – 2027 (USD Million)
7.9.8.2. Market estimates and forecast, by treatment, 2016 – 2027 (USD Million)
7.9.8.3. Market estimates and forecast, by therapy, 2016 – 2027 (USD Million)
7.9.9. South Korea
7.9.9.1. Market estimates and forecast, by type, 2016 – 2027 (USD Million)
7.9.9.2. Market estimates and forecast, by treatment, 2016 – 2027 (USD Million)
7.9.9.3. Market estimates and forecast, by therapy, 2016 – 2027 (USD Million)
7.10. Latin America
7.10.1. Market estimates and forecast, by country, 2016 – 2027 (USD Million)
7.10.2. Market estimates and forecast, by type, 2016 – 2027 (USD Million)
7.10.3. Market estimates and forecast, by treatment, 2016 – 2027 (USD Million)
7.10.4. Market estimates and forecast, by therapy, 2016 – 2027 (USD Million)
7.10.5. Brazil
7.10.5.1. Market estimates and forecast, by type, 2016 – 2027 (USD Million)
7.10.5.2. Market estimates and forecast, by treatment, 2016 – 2027 (USD Million)
7.10.5.3. Market estimates and forecast, by therapy, 2016 – 2027 (USD Million)
7.10.6. Mexico
7.10.6.1. Market estimates and forecast, by type, 2016 – 2027 (USD Million)
7.10.6.2. Market estimates and forecast, by treatment, 2016 – 2027 (USD Million)
7.10.6.3. Market estimates and forecast, by therapy, 2016 – 2027 (USD Million)
7.10.7. Argentina
7.10.7.1. Market estimates and forecast, by type, 2016 – 2027 (USD Million)
7.10.7.2. Market estimates and forecast, by treatment, 2016 – 2027 (USD Million)
7.10.7.3. Market estimates and forecast, by therapy, 2016 – 2027 (USD Million)
7.10.8. Colombia
7.10.8.1. Market estimates and forecast, by type, 2016 – 2027 (USD Million)
7.10.8.2. Market estimates and forecast, by treatment, 2016 – 2027 (USD Million)
7.10.8.3. Market estimates and forecast, by therapy, 2016 – 2027 (USD Million)
7.11. Middle East and Africa
7.11.1. Market estimates and forecast, by country, 2016 – 2027 (USD Million)
7.11.2. Market estimates and forecast, by type, 2016 – 2027 (USD Million)
7.11.3. Market estimates and forecast, by treatment, 2016 – 2027 (USD Million)
7.11.4. Market estimates and forecast, by therapy, 2016 – 2027 (USD Million)
7.11.5. South Africa
7.11.5.1. Market estimates and forecast, by type, 2016 – 2027 (USD Million)
7.11.5.2. Market estimates and forecast, by treatment, 2016 – 2027 (USD Million)
7.11.5.3. Market estimates and forecast, by therapy, 2016 – 2027 (USD Million)
7.11.6. Saudi Arabia
7.11.6.1. Market estimates and forecast, by type, 2016 – 2027 (USD Million)
7.11.6.2. Market estimates and forecast, by treatment, 2016 – 2027 (USD Million)
7.11.6.3. Market estimates and forecast, by therapy, 2016 – 2027 (USD Million)
7.11.7. UAE
7.11.7.1. Market estimates and forecast, by type, 2016 – 2027 (USD Million)
7.11.7.2. Market estimates and forecast, by treatment, 2016 – 2027 (USD Million)
7.11.7.3. Market estimates and forecast, by therapy, 2016 – 2027 (USD Million)
Chapter 8. Hemophilia market – Competitive Analysis
8.1. Recent developments & impact analysis, by key market participants
8.2. Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
8.3. Public Companies
8.3.1. Company market position analysis (Revenue, geographic presence, product portfolio, key serviceable industries, key alliances)
8.3.2. Company Market Share/Ranking, by region
8.3.3. Competitive Dashboard Analysis
8.4. Private Companies
8.4.1. List of key emerging companies/technology disruptors/innovators
8.4.2. Regional network map
8.4.3. Company market position analysis
8.5. Key companies profiles
8.5.1. Novo Nordisk A/S
8.5.1.1. Company Overview
8.5.1.2. Financial Performance
8.5.1.3. Product Benchmarking
8.5.1.4. Strategic Initiatives
8.5.2. Shire
8.5.2.1. Company Overview
8.5.2.2. Financial Performance
8.5.2.3. Product Benchmarking
8.5.2.4. Strategic Initiatives
8.5.3. Chugai Pharmaceutical Co. Ltd.
8.5.3.1. Company Overview
8.5.3.2. Financial Performance
8.5.3.3. Product Benchmarking
8.5.3.4. Strategic Initiatives
8.5.4. Bayer AG
8.5.4.1. Company Overview
8.5.4.2. Financial Performance
8.5.4.3. Product Benchmarking
8.5.4.4. Strategic Initiatives
8.5.5. Pfizer, Inc.
8.5.5.1. Company Overview
8.5.5.2. Financial Performance
8.5.5.3. Product Benchmarking
8.5.5.4. Strategic Initiatives
8.5.6. CSL Behring
8.5.6.1. Company Overview
8.5.6.2. Financial Performance
8.5.6.3. Product Benchmarking
8.5.6.4. Strategic Initiatives
8.5.7. BioMarin
8.5.7.1. Company Overview
8.5.7.2. Financial Performance
8.5.7.3. Product Benchmarking
8.5.7.4. Strategic Initiatives
8.5.8. Octopharma AG
8.5.8.1. Company Overview
8.5.8.2. Financial Performance
8.5.8.3. Product Benchmarking
8.5.8.4. Strategic Initiatives
8.5.9. Genzyme Corporation
8.5.9.1. Company Overview
8.5.9.2. Financial Performance
8.5.9.3. Product Benchmarking
8.5.9.4. Strategic Initiatives
8.5.10. Spark Therapeutics, Inc.
8.5.10.1. Company Overview
8.5.10.2. Financial Performance
8.5.10.3. Product Benchmarking
8.5.10.4. Strategic Initiatives

List of Tables

TABLE 1 Digital marketing software market - Industry snapshot & key buying criteria, 2016 - 2027
TABLE 2 Global digital marketing software market, 2016 - 2027 (USD Million)
TABLE 3 Global digital marketing software market, by region, 2016 - 2027 (USD Million)
TABLE 4 Global digital marketing software market, by solution, 2016 - 2027 (USD Million)
TABLE 5 Global digital marketing software market, by service, 2016 - 2027 (USD Million)
TABLE 6 Global digital marketing software market, by deployment, 2016 - 2027 (USD Million)
TABLE 7 Global digital marketing software market, by enterprise size, 2016 - 2027 (USD Million)
TABLE 8 Global digital marketing software market, by end use, 2016 - 2027 (USD Million)
TABLE 9 Vendor landscape
TABLE 10 CRM digital marketing software market, 2016 - 2027 (USD Million)
TABLE 11 CRM digital marketing software market, by region, 2016 - 2027 (USD Million)
TABLE 12 Email digital marketing software market, 2016 - 2027 (USD Million)
TABLE 13 Email digital marketing software market, by region, 2016 - 2027 (USD Million)
TABLE 14 Social media digital marketing software market, 2016 - 2027 (USD Million)
TABLE 15 Social media digital marketing software market, by region, 2016 - 2027 (USD Million)
TABLE 16 Search digital marketing software market, 2016 - 2027 (USD Million)
TABLE 17 Search digital marketing software market, by region, 2016 - 2027 (USD Million)
TABLE 18 Content management digital marketing software market, 2016 - 2027 (USD Million)
TABLE 19 Content management digital marketing software market, by region, 2016 - 2027 (USD Million)
TABLE 20 Marketing automation digital marketing software market, 2016 - 2027 (USD Million)
TABLE 21 Marketing automation digital marketing software market, by region, 2016 - 2027 (USD Million)
TABLE 22 Campaign management digital marketing software market, 2016 - 2027 (USD Million)
TABLE 23 Campaign management digital marketing software market, by region, 2016 - 2027 (USD Million)
TABLE 24 Other digital marketing software market, 2016 - 2027 (USD Million)
TABLE 25 Other digital marketing software market, by region, 2016 - 2027 (USD Million)
TABLE 26 Digital marketing professional services market, 2016 - 2027 (USD Million)
TABLE 27 Digital marketing professional services market, by region, 2016 - 2027 (USD Million)
TABLE 28 Digital marketing managed services market, 2016 - 2027 (USD Million)
TABLE 29 Digital marketing managed services market, by region, 2016 - 2027 (USD Million)
TABLE 30 Cloud-based digital marketing software market, 2016 - 2027 (USD Million)
TABLE 31 Cloud-based digital marketing software market, by region, 2016 - 2027 (USD Million)
TABLE 32 On-premise digital marketing software market, 2016 - 2027 (USD Million)
TABLE 33 On-premise digital marketing software market, by region, 2016 - 2027 (USD Million)
TABLE 34 Digital marketing software market in large enterprises, 2016 - 2027 (USD Million)
TABLE 35 Digital marketing software market in large enterprises, by region, 2016 - 2027 (USD Million)
TABLE 36 Digital marketing software market in SMEs, 2016 - 2027 (USD Million)
TABLE 37 Digital marketing software market in SMEs, by region, 2016 - 2027 (USD Million)
TABLE 38 Digital marketing software market in automotive, 2016 - 2027 (USD Million)
TABLE 39 Digital marketing software market in automotive, by region, 2016 - 2027 (USD Million)
TABLE 40 Digital marketing software market in BFSI, 2016 - 2027 (USD Million)
TABLE 41 Digital marketing software market in BFSI, by region, 2016 - 2027 (USD Million)
TABLE 42 Digital marketing software market in education, 2016 - 2027 (USD Million)
TABLE 43 Digital marketing software market in education, by region, 2016 - 2027 (USD Million)
TABLE 44 Digital marketing software market in government, 2016 - 2027 (USD Million)
TABLE 45 Digital marketing software market in government, by region, 2016 - 2027 (USD Million)
TABLE 46 Digital marketing software market in healthcare, 2016 - 2027 (USD Million)
TABLE 47 Digital marketing software market in healthcare, by region, 2016 - 2027 (USD Million)
TABLE 48 Digital marketing software market in manufacturing, 2016 - 2027 (USD Million)
TABLE 49 Digital marketing software market in manufacturing, by region, 2016 - 2027 (USD Million)
TABLE 50 Digital marketing software market in media & entertainment, 2016 - 2027 (USD Million)
TABLE 51 Digital marketing software market in media & entertainment, by region, 2016 - 2027 (USD Million)
TABLE 52 Digital marketing software market in other end uses, 2016 - 2027 (USD Million)
TABLE 53 Digital marketing software market in other end uses, by region, 2016 - 2027 (USD Million)
TABLE 54 North America digital marketing software market, 2016 - 2027 (USD Million)
TABLE 55 North America digital marketing software market, by solution, 2016 - 2027 (USD Million)
TABLE 56 North America digital marketing software market, by service, 2016 - 2027 (USD Million)
TABLE 57 North America digital marketing software market, by deployment, 2016 - 2027 (USD Million)
TABLE 58 North America digital marketing software market, by enterprise size, 2016 - 2027 (USD Million)
TABLE 59 North America digital marketing software market, by end use, 2016 - 2027 (USD Million)
TABLE 60 U.S. digital marketing software market, 2016 - 2027 (USD Million)
TABLE 61 U.S. digital marketing software market, by solution, 2016 - 2027 (USD Million)
TABLE 62 U.S. digital marketing software market, by service, 2016 - 2027 (USD Million)
TABLE 63 U.S. digital marketing software market, by deployment, 2016 - 2027 (USD Million)
TABLE 64 U.S. digital marketing software market, by enterprise size, 2016 - 2027 (USD Million)
TABLE 65 U.S. digital marketing software market, by end use, 2016 - 2027 (USD Million)
TABLE 66 Canada digital marketing software market, 2016 - 2027 (USD Million)
TABLE 67 Canada digital marketing software market, by solution, 2016 - 2027 (USD Million)
TABLE 68 Canada digital marketing software market, by service, 2016 - 2027 (USD Million)
TABLE 69 Canada digital marketing software market, by deployment, 2016 - 2027 (USD Million)
TABLE 70 Canada digital marketing software market, by enterprise size, 2016 - 2027 (USD Million)
TABLE 71 Canada digital marketing software market, by end use, 2016 - 2027 (USD Million)
TABLE 72 Europe digital marketing software market, 2016 - 2027 (USD Million)
TABLE 73 Europe digital marketing software market, by solution, 2016 - 2027 (USD Million)
TABLE 74 Europe digital marketing software market, by service, 2016 - 2027 (USD Million)
TABLE 75 Europe digital marketing software market, by deployment, 2016 - 2027 (USD Million)
TABLE 76 Europe digital marketing software market, by enterprise size, 2016 - 2027 (USD Million)
TABLE 77 Europe digital marketing software market, by end use, 2016 - 2027 (USD Million)
TABLE 78 U.K. digital marketing software market, 2016 - 2027 (USD Million)
TABLE 79 U.K. digital marketing software market, by solution, 2016 - 2027 (USD Million)
TABLE 80 U.K. digital marketing software market, by service, 2016 - 2027 (USD Million)
TABLE 81 U.K. digital marketing software market, by deployment, 2016 - 2027 (USD Million)
TABLE 82 U.K. digital marketing software market, by enterprise size, 2016 - 2027 (USD Million)
TABLE 83 U.K. digital marketing software market, by end use, 2016 - 2027 (USD Million)
TABLE 84 Germany digital marketing software market, 2016 - 2027 (USD Million)
TABLE 85 Germany digital marketing software market, by solution, 2016 - 2027 (USD Million)
TABLE 86 Germany digital marketing software market, by service, 2016 - 2027 (USD Million)
TABLE 87 Germany digital marketing software market, by deployment, 2016 - 2027 (USD Million)
TABLE 88 Germany digital marketing software market, by enterprise size, 2016 - 2027 (USD Million)
TABLE 89 Germany digital marketing software market, by end use, 2016 - 2027 (USD Million)
TABLE 90 France digital marketing software market, 2016 - 2027 (USD Million)
TABLE 91 France digital marketing software market, by solution, 2016 - 2027 (USD Million)
TABLE 92 France digital marketing software market, by service, 2016 - 2027 (USD Million)
TABLE 93 France digital marketing software market, by deployment, 2016 - 2027 (USD Million)
TABLE 94 France digital marketing software market, by enterprise size, 2016 - 2027 (USD Million)
TABLE 95 France digital marketing software market, by end use, 2016 - 2027 (USD Million)
TABLE 96 Asia Pacific digital marketing software market, 2016 - 2027 (USD Million)
TABLE 97 Asia Pacific digital marketing software market, by solution, 2016 - 2027 (USD Million)
TABLE 98 Asia Pacific digital marketing software market, by service, 2016 - 2027 (USD Million)
TABLE 99 Asia Pacific digital marketing software market, by deployment, 2016 - 2027 (USD Million)
TABLE 100 Asia Pacific digital marketing software market, by enterprise size, 2016 - 2027 (USD Million)
TABLE 101 Asia Pacific digital marketing software market, by end use, 2016 - 2027 (USD Million)
TABLE 102 China digital marketing software market, 2016 - 2027 (USD Million)
TABLE 103 China digital marketing software market, by solution, 2016 - 2027 (USD Million)
TABLE 104 China digital marketing software market, by service, 2016 - 2027 (USD Million)
TABLE 105 China digital marketing software market, by deployment, 2016 - 2027 (USD Million)
TABLE 106 China digital marketing software market, by enterprise size, 2016 - 2027 (USD Million)
TABLE 107 China digital marketing software market, by end use, 2016 - 2027 (USD Million)
TABLE 108 India digital marketing software market, 2016 - 2027 (USD Million)
TABLE 109 India digital marketing software market, by solution, 2016 - 2027 (USD Million)
TABLE 110 India digital marketing software market, by service, 2016 - 2027 (USD Million)
TABLE 111 India digital marketing software market, by deployment, 2016 - 2027 (USD Million)
TABLE 112 India digital marketing software market, by enterprise size, 2016 - 2027 (USD Million)
TABLE 113 India digital marketing software market, by end use, 2016 - 2027 (USD Million)
TABLE 114 Japan digital marketing software market, 2016 - 2027 (USD Million)
TABLE 115 Japan digital marketing software market, by solution, 2016 - 2027 (USD Million)
TABLE 116 Japan digital marketing software market, by service, 2016 - 2027 (USD Million)
TABLE 117 Japan digital marketing software market, by deployment, 2016 - 2027 (USD Million)
TABLE 118 Japan digital marketing software market, by enterprise size, 2016 - 2027 (USD Million)
TABLE 119 Japan digital marketing software market, by end use, 2016 - 2027 (USD Million)
TABLE 120 Latin America digital marketing software market, 2016 - 2027 (USD Million)
TABLE 121 Latin America digital marketing software market, by solution, 2016 - 2027 (USD Million)
TABLE 122 Latin America digital marketing software market, by service, 2016 - 2027 (USD Million)
TABLE 123 Latin America digital marketing software market, by deployment, 2016 - 2027 (USD Million)
TABLE 124 Latin America digital marketing software market, by enterprise size, 2016 - 2027 (USD Million)
TABLE 125 Latin America digital marketing software market, by end use, 2016 - 2027 (USD Million)
TABLE 126 Brazil digital marketing software market, 2016 - 2027 (USD Million)
TABLE 127 Brazil digital marketing software market, by solution, 2016 - 2027 (USD Million)
TABLE 128 Brazil digital marketing software market, by service, 2016 - 2027 (USD Million)
TABLE 129 Brazil digital marketing software market, by deployment, 2016 - 2027 (USD Million)
TABLE 130 Brazil digital marketing software market, by enterprise size, 2016 - 2027 (USD Million)
TABLE 131 Brazil digital marketing software market, by end use, 2016 - 2027 (USD Million)
TABLE 132 MEA digital marketing software market, 2016 - 2027 (USD Million)
TABLE 133 MEA digital marketing software market, by solution, 2016 - 2027 (USD Million)
TABLE 134 MEA digital marketing software market, by service, 2016 - 2027 (USD Million)
TABLE 135 MEA digital marketing software market, by deployment, 2016 - 2027 (USD Million)
TABLE 136 MEA digital marketing software market, by enterprise size, 2016 - 2027 (USD Million)
TABLE 137 MEA digital marketing software market, by end use, 2016 - 2027 (USD Million)


List of Figures

FIG. 1 Market segmentation and scope
FIG. 2 Global digital marketing software market, 2016 - 2027 (USD Million)
FIG. 3 Digital marketing software market - Value chain analysis
FIG. 4 Digital marketing software market - Market dynamics
FIG. 5 Digital marketing software market - Key market driver impact
FIG. 6 Digital marketing software market - Key market restraint impact
FIG. 7 Key opportunities prioritized
FIG. 8 Digital marketing software market - Porter’s five forces analysis
FIG. 9 Digital marketing software market - PESTEL analysis
FIG. 10 Digital marketing software market, by solution, 2019
FIG. 11 Digital marketing software market, by service, 2019
FIG. 12 Digital marketing software market, by deployment, 2019
FIG. 13 Digital marketing software market, by enterprise size, 2019
FIG. 14 Digital marketing software market, by end use, 2019
FIG. 15 Digital marketing software market, by region, 2019
FIG. 16 Digital marketing software market - Regional takeaways
FIG. 17 North America digital marketing software market - Key takeaways
FIG. 18 Europe digital marketing software market - Key takeaways
FIG. 19 Asia Pacific digital marketing software market - Key takeaways
FIG. 20 Latin America digital marketing software market - Key takeaways
FIG. 21 MEA digital marketing software market - Key takeaways

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 血友病の世界市場2020-2027:市場規模、シェア、動向分析(Hemophilia Market Size, Share & Trends Analysis Report By Type (Type A, Type B, Type C), By Treatment (On-demand, Prophylaxis), By Therapy (Replacement Therapy, Gene Therapy), By Region, And Segment Forecasts, 2020 - 2027)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆